Sanofi Not Distracted By M&A Chatter As It Gets Back On Par With Market Growth

Recent market interest shown in other OTC assets will not distract Sanofi from its long-term plan to overhaul its Consumer Healthcare business, says CEO Paul Hudson. And this plan is delivering results, with Sanofi back on par with the consumer health market, posting sales up by 5% in 2021.

Sanofi Lyon
• Source: Alamy

Now its Consumer Healthcare business is back on the right track, Sanofi has no plans to change the direction of travel.

Asked by analysts on the French firm’s Q4 earnings call if the recent market interest in other OTC assets would...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Europe

More from Geography